- OncoCyte is reporting earnings from Q4 on March 29.
- Analysts expect losses per share of $0.094.
- Go here to watch OncoCyte stock price in real-time on Markets Insider.
On March 29, OncoCyte is reporting latest earnings.
Forecasts of 5 analysts expect losses of $0.094 per share compared to losses of $0.390 per share from the same quarter last year.
Wall Street expects sales to decrease by 60.45% over the previous year’s quarter to $3.6 million.
Analysts expect a loss of $0.359 per share this year. A year earlier, the company lost $0.720 per share.
This story was written by Markets Insider’s RoboEddy, which automatically writes these stories based on data provided by our partners.
